<html>
<head>
    <meta http-equiv="content-type" content="text/html; charset=utf-8" />
    <meta name="description" content="" />
    <meta name="keywords" content="" />
    <!--[if lte IE 8]><script src="css/ie/html5shiv.js"></script><![endif]-->
    <script src="/js/jquery.min.js"></script>
    <script src="/js/jquery.dropotron.min.js"></script>
    <script src="/js/skel.min.js"></script>
    <script src="/js/skel-layers.min.js"></script>
    <script src="/js/init.js"></script>
    <script src="/js/lightbox.js"></script>
    <link rel="stylesheet" href="/css/pygment.css"/>
    <noscript>
        <link rel="stylesheet" href="/css/skel.css" />
        <link rel="stylesheet" href="/css/style.css" />
        <link rel="stylesheet" href="/css/style-noscript.css" />
        <link href="/css/lightbox.css" rel="stylesheet"/>
    </noscript>
    <script src="//cdnjs.cloudflare.com/ajax/libs/modernizr/2.6.2/modernizr.min.js"></script>
    <!-- <link href="//netdna.bootstrapcdn.com/font-awesome/4.1.0/css/font-awesome.min.css" rel="stylesheet"> -->
    <link rel="stylesheet" href="//cdn.materialdesignicons.com/1.3.41/css/materialdesignicons.min.css">
    <link  href="http://fonts.googleapis.com/css?family=Anonymous+Pro:regular,italic,bold,bolditalic" rel="stylesheet" type="text/css" >
    <!--[if lte IE 8]><link rel="stylesheet" href="/css/ie/v8.css" /><![endif]-->
    <!--[if lte IE 9]><link rel="stylesheet" href="/css/ie/v9.css" /><![endif]-->
    <style>
    body, #skel-layers-wrapper {
    background: #CFF4EF;}
    </style>

    <!-- Favicon for all devices and sizes -->
    <link rel="apple-touch-icon-precomposed" sizes="57x57" href="/apple-touch-icon-57x57.png" />
    <link rel="apple-touch-icon-precomposed" sizes="114x114" href="/apple-touch-icon-114x114.png" />
    <link rel="apple-touch-icon-precomposed" sizes="72x72" href="/apple-touch-icon-72x72.png" />
    <link rel="apple-touch-icon-precomposed" sizes="144x144" href="/apple-touch-icon-144x144.png" />
    <link rel="apple-touch-icon-precomposed" sizes="60x60" href="/apple-touch-icon-60x60.png" />
    <link rel="apple-touch-icon-precomposed" sizes="120x120" href="/apple-touch-icon-120x120.png" />
    <link rel="apple-touch-icon-precomposed" sizes="76x76" href="/apple-touch-icon-76x76.png" />
    <link rel="apple-touch-icon-precomposed" sizes="152x152" href="/apple-touch-icon-152x152.png" />
    <link rel="icon" type="image/png" href="/favicon-196x196.png" sizes="196x196" />
    <link rel="icon" type="image/png" href="/favicon-96x96.png" sizes="96x96" />
    <link rel="icon" type="image/png" href="/favicon-32x32.png" sizes="32x32" />
    <link rel="icon" type="image/png" href="/favicon-16x16.png" sizes="16x16" />
    <link rel="icon" type="image/png" href="/favicon-128.png" sizes="128x128" />
    <meta name="application-name" content="&nbsp;"/>
    <meta name="msapplication-TileColor" content="#FFFFFF" />
    <meta name="msapplication-TileImage" content="/mstile-144x144.png" />
    <meta name="msapplication-square70x70logo" content="/mstile-70x70.png" />
    <meta name="msapplication-square150x150logo" content="/mstile-150x150.png" />
    <meta name="msapplication-wide310x150logo" content="/mstile-310x150.png" />
    <meta name="msapplication-square310x310logo" content="/mstile-310x310.png" />


    <title>Leena Latonen | Yeo Lab </title>
        <meta charset="utf-8" />
        <meta name="viewport" content="width=device-width">
</head>

<body class=" loading">



    <!-- Header -->
    <header id="header" >
        <h1 class="logo">
            <a href="..">Yeo Lab</a>
        </h1>
        <nav id="nav">
            <ul>
                <!-- <li class="current"><a href="index.html">Welcome</a></li> -->
                    <li><a href="/research/">Research</a></li>
                    <li><a href="/papers/">Papers</a></li>
                    <li><a href="/funding/">Funding</a></li>
                    <li><a href="/software/">Software</a></li>
                    <li><a href="/links/">Links</a></li>
                <li><a href="/people" class="button special">People</a></li>
            </ul>
        </nav>
    </header>

<style>
.image:before{
  background-image: None;
}
img.clown {
  height: 100%;
  /*Border-radius 50% makes it a circle*/
  border-radius: 50%;
  margin-top: -49px;
}
</style>
<!-- Main -->
<article id="main">

  <header class="special container">
    <span class="icon"><img src="/images/people/leena_latonen.png" class="clown"></span>
    <h2>Leena&nbsp;Latonen</h2>
    <!-- add page sub title here -->
    <p>Visiting Scientists

      <!-- If there's a position suffix
      (e.g. Bioinformatics Analyst "I, (Ph.D.))"", add it -->

      <!-- If they are alumni, specify -->
        Alumni
<br>

      <!-- Add program/department affiliation, if applicable -->

    <!-- Add their fellowship, if applicable -->
    llatonen at ucsd.edu</p>
  </header>

  <!-- One -->
    <section class="wrapper style4 container">

      <!-- Content -->
        <div class="content">
          <section>
            <p><!-- Status: draft -->

<h2>Degrees</h2>
<p>Ph.D., Cancer biology, University of Helsinki, Finland, 2003<br></p>
<h2>Summary</h2>
<p>Leena is a cell and cancer biologist. Her Ph.D. work focused on the regulation of p53 pathway in the cellular stress responses induced by <span class="caps">DNA</span> damage and proteotoxic stress. During her postdoctoral work she identified a nuclear stress response granule, the nucleolar aggresome, forming under inhibition of the proteasome and serving as a site of aggregation for many nuclear factors and poly-A <span class="caps">RNA</span>. Her interests continue to include the crosstalk between stress and cancer through regulation of key cancer-relevant transcription factors.
Leena’s current work focuses on identifying novel disease mechanisms in prostate cancer. Her work includes studying the regulation of Androgen receptor (<span class="caps">AR</span>) and it’s downstream effectors, especially roles of non-coding <span class="caps">AR</span> target genes. She is also interested in development of computational tools for 3D tissue analysis and digital pathology of cancer. Based on a recently performed large scale proteomics on clinical prostate cancer samples, she has identified novel factors and pathways de-regulated prostate cancer. In Dr. Yeo’s lab, she is interested in the <span class="caps">RNA</span> binding functions of the newly identified prostate cancer-relevant&nbsp;factors.</p>
<h2>Publications</h2>
<ul>
<li>
<p><strong>Latonen L</strong>, Afyounian E, Jylhä A, Nättinen J, Aapola U, Annala M, Kivinummi <span class="caps">KK</span>, Tammela <span class="caps">TLJ</span>, Beuerman <span class="caps">RW</span>, Uusitalo H, Nykter M, Visakorpi T. Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression. Nature Communications, 9:1176 (2018).&nbsp;doi:10.1038/s41467-018-03573-6</p>
</li>
<li>
<p>Ehteshami Bejnordi B, Veta M, Johannes van Diest P, van Ginneken B, Karssemeijer N, Litjens G, van der Laak <span class="caps">JAWM</span>; the <span class="caps">CAMELYON16</span> Consortium, Hermsen M, Manson <span class="caps">QF</span>, Balkenhol M, Geessink O, Stathonikos N, van Dijk <span class="caps">MC</span>, Bult P, Beca F, Beck <span class="caps">AH</span>, Wang D, Khosla A, Gargeya R, Irshad H, Zhong A, Dou Q, Li Q, Chen H, Lin <span class="caps">HJ</span>, Heng <span class="caps">PA</span>, Haß C, Bruni E, Wong Q, Halici U, Öner MÜ, Cetin-Atalay R, Berseth M, Khvatkov V, Vylegzhanin A, Kraus O, Shaban M, Rajpoot N, Awan R, Sirinukunwattana K, Qaiser T, Tsang <span class="caps">YW</span>, Tellez D, Annuscheit J, Hufnagl P, Valkonen M, Kartasalo K, <strong>Latonen L</strong>, Ruusuvuori P, Liimatainen K, Albarqouni S, Mungal B, George A, Demirci S, Navab N, Watanabe S, Seno S, Takenaka Y, Matsuda H, Ahmady Phoulady H, Kovalev V, Kalinovsky A, Liauchuk V, Bueno G, Fernandez-Carrobles <span class="caps">MM</span>, Serrano I, Deniz O, Racoceanu D, Venâncio R. Diagnostic  assessment  of  deep  learning  algorithms  for detection of lymph node metastases in women with breast cancer. . <span class="caps">JAMA</span> 318:2199-2210 (2017). <span class="caps">PMID</span>:&nbsp;29234806</p>
</li>
<li>
<p><strong>* Latonen L</strong>, Scaravilli M, Gillen A, Hartikainen S, Zhang <span class="caps">FP</span>, Ruusuvuori P, Kujala P, Poutanen M, Visakorpi T. In vivo expression of miR-32 induces proliferation in prostate epithelium. American Journal of Pathology 187:2546-2557 (2017). <span class="caps">PMID</span>:&nbsp;28827140</p>
</li>
<li>
<p>Valkonen M, Ruusuvuori P, Nykter M, Visakorpi T, <strong>Latonen L</strong>. Analysis of spatial heterogeneity in normal epithelium and preneoplastic alterations in mouse prostate tumor models Scientific Reports 7:44831 (2017). <span class="caps">PMID</span>:&nbsp;28317907</p>
</li>
<li>
<p>Valkonen M, Kartasalo K, Liimatainen K, Nykter M, <strong>Latonen L</strong>, Ruusuvuori P. Metastasis detection from whole slide images using local features and random forests. Cytometry A 91:555-5659 (2017). <span class="caps">PMID</span>: 28426134
Latonen L, Leinonen <span class="caps">KA</span>, Grönlund T, Vessella <span class="caps">RL</span>, Tammela <span class="caps">TLJ</span>, Saramäki <span class="caps">OR</span>, Visakorpi T. Chromosomal amplification of 9p13.3 in prostate cancer. Genes, Chromosomes and Cancer 55:617-25 (2016). <span class="caps">PMID</span>: 27074291
Ylipää A, Kivinummi K, Kohvakka A, Annala M, Latonen L, Scaravilli M, Kartasalo K, Leppänen S-P, Karakurt S, Seppälä J, Yli-Harja O, Tammela <span class="caps">TLJ</span>, Zhang W, Visakorpi T, Nykter M. Transcriptome sequencing reveals <span class="caps">PCAT5</span> - an <span class="caps">ERG</span>-regulated non-coding transcript in prostate cancer. Cancer Research 75:4026-31 (2015). <span class="caps">PMID</span>:&nbsp;26282172</p>
</li>
<li>
<p>Jalava <span class="caps">SE</span>, Urbanucci A, <strong>Latonen L</strong>, Waltering <span class="caps">KK</span>, Sahu B, Jänne <span class="caps">OA</span>, Seppälä J,  Lähdesmäki H, Tammela <span class="caps">TLJ</span>, Visakorpi T. Androgen-regulated miR-32 targets <span class="caps">BTG2</span> and is overexpressed in castration-resistant prostate cancer. Oncogene, 31:4460-71 (2012). <span class="caps">PMID</span>:&nbsp;22266859</p>
</li>
<li>
<p><strong>Latonen L</strong>. Nucleolar aggresomes as counterparts of cytoplasmic aggresomes in proteotoxic stress: proteasome inhibitors induce nuclear ribonucleoprotein inclusions trapping several key factors of neurodegenerative diseases and cancer. BioEssays 33, 386-395 (2011). <span class="caps">PMID</span>:&nbsp;21425306</p>
</li>
<li>
<p><strong>Latonen L</strong>, Moore <span class="caps">HM</span>, Bai B, Jäämaa S, Laiho M. Proteasome inhibitors induce nucleolar aggregation of proteasome target proteins and polyadenylated <span class="caps">RNA</span> by altering ubiquitin availability. Oncogene 30: 790-805 (2011). <span class="caps">PMID</span>:&nbsp;20956947</p>
</li>
<li>
<p><strong>Latonen L</strong>, Järvinen <span class="caps">PM</span>, Laiho M. Cytoskeleton-interacting <span class="caps">LIM</span>-domain protein <span class="caps">CRP1</span> suppresses cell proliferation and protects from stress-induced cell death. Experimental Cell Research 314, 738-47 (2008). <span class="caps">PMID</span>:&nbsp;18177859</p>
</li>
<li>
<p>Rahman R, <strong>Latonen L</strong>, Wiman <span class="caps">KG</span>. hTERT antagonizes p53-induced apoptosis independently of telomerase activity. Oncogene 24, 1320-7 (2005). <span class="caps">PMID</span>: 15608686
Latonen L, Laiho M. Cellular <span class="caps">UV</span> damage responses - functions of tumor suppressor p53. Biochimica et Biophysica Acta 1755, 71-89 (2005). <span class="caps">PMID</span>: 15921859
Kurki S, Peltonen K, Latonen L, Kiviharju <span class="caps">TM</span>, Ojala <span class="caps">PM</span>, Meek D, Laiho M. Nucleolar protein <span class="caps">NPM</span> interacts with <span class="caps">HDM2</span> and protects tumor suppressor protein p53 from <span class="caps">HDM2</span>-mediated degradation. Cancer Cell 5, 465-75 (2004). <span class="caps">PMID</span>:&nbsp;15144954</p>
</li>
<li>
<p><strong>Latonen L</strong>, Taya Y, Laiho M. <span class="caps">UV</span>-radiation induces dose-dependent regulation of p53 response and modulates p53-<span class="caps">HDM2</span> interaction in human fibroblasts. Oncogene 20, 6784-6793 (2001). <span class="caps">PMID</span>:&nbsp;11709713</p>
</li>
</ul></p>
          </section>
        </div>

    </section>

  </article>


<!-- Footer -->

<style>
#footer .mdi{
  font-size: 4em;
}
</style>

<footer id="footer">

    <ul class="icons">
        <li>
          <a href="http://github.com/yeolab" class="mdi mdi-github-circle"><span class="label"></span></a>
        </li>
        <li>
          <a href="http://twitter.com/yeo_lab" class="mdi mdi-twitter-circle"><span class="label"></span></a>
        </li>
    </ul>

    <span class="copyright">&copy; Yeo Lab. All rights reserved. Design: <a href="http://html5up.net">HTML5 UP</a>.</span>

</footer>
</body>
</html>